At least a repeat of ATH this hasn't happened to IHL (yet).
By the way. IHL is on a $132Mill MC.
Just a few months ago we were only in the $30Mill MC. Goes to show how quick things can change. Can't say it was an easy few months but nevertheless I'm glad we're in the clear.
As of current it looks like 14cents is going to be our next breakthrough/test barrier at these levels. Hopefully not for long as the sell side is quite small in comparison. We discussed that 15cents was going to be our next point to roughly settle on and we're close to it.
Still underrated and undervalued imo.
GLTA![]()
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-113
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online